Skip to main content

Antidepressive Action of Rubidium

  • Conference paper
Recurrent Mood Disorders
  • 79 Accesses

Abstract

The discovery of rubidium goes back to 1861 when Bunsen and Kirkhoff isolated it from rocks containing lepidolite. Therefore, its use in therapy only began in 1880, with its employment against epilepsy, syphilis, and cardiac insufficiency. Most patients treated with rubidium showed a reduction in heart rate, an increase in blood pressure and, above all, a psychic sense of well-being.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abou-Saleh MT, Coppen A (1989) The efficacy of low-dose lithium: clinical, physiological and biological correlates. J Psychiatr Res 23/2: 157–162.

    Article  Google Scholar 

  • Belmaker RA, Hamburger-Barr R et al. (1984) The effect of rubidium and lithium on adenylate cyclase and neurotransmitter receptors. In: Corsini GU (ed) Current trends in lithium and rubidium therapy. MTP Press, Lancaster, pp 59–75.

    Google Scholar 

  • Casacchia M, Rossi A, Marola V et al. (1984) The use of rubidium chloride in depressive disorder: clinical aspects. In: Corsini GU (ed) Current trends in lithium and rubidium therapy. MTP Press, Lancaster, pp 255–259.

    Google Scholar 

  • Corsini GU, Reda M, Burrai C et al. (1984) Preliminary results with rubidium in depressed patients. In: Corsini GU (ed) Current trends in lithium and rubidium therapy. MTP Press, Lancaster, pp 247–253.

    Google Scholar 

  • De Maio D et al. (1989) Metabolismo del litio e liposomi di fosfolipidi ipotalamici. In: Atti del 37 congresso nazionale della Societa Italiana di Psichiatria, 6-11 Feb 1989, Rome. CIC Internazionali, Rome, Suppl II, pp 243-251.

    Google Scholar 

  • Fieve RR, Meltzer HL (1974) Rubidium salts: toxic effects in human and clinical effects as an antidepressant drug. Psychopharmacol Bull 1: 38–50..

    Google Scholar 

  • Fieve RR, Jamison KR, Goodnick PJ (1985) The use of lithium and experimental rubidium in psychiatry. In: Gabay S et al. (eds) Metal ions in neurology and psychiatry. Liss, New York, pp 107–120.

    Google Scholar 

  • Geisler A, Klysner R, Andersen PH (1984) Opposite effects of lithium and rubidium on neuro-hormone-stimulating cyclic-AMP accumulation in rat brain homogenates. In: Corsini GU(ed) Current trends in lithium and rubidium therapy. MTP Press, Lancaster, pp 37–55.

    Google Scholar 

  • Meltzer HL, Taylor RM, Platman SR, Fieve RR (1969) Rubidium; a potential modifier of affect and behavior. Nature 233: 321–322.

    Article  Google Scholar 

  • Sarteschi P, Placidi GF, Lanzi A et al. (1984) Rubidium salts in depressed patients. An open pilot study standardized techniques. In: Corsini GU (ed) Current trends in lithium and rubidium therapy. MTP Press, Lancaster, pp 225–246.

    Google Scholar 

  • Simon P (1978) Que peut apporter la pharmacologie experimentale à l’étude des antidépresseurs ? In: Pichot P (ed) Les voies normelles de la depression. Masson, Paris, pp 162–168.

    Google Scholar 

  • Stolk JM, Nowack WJ, Baargas JD (1970) Brain norepinephrine: enhanced turnover after rubidium treatment. Science 168: 501–503.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

De Maio, D., Buffa, G., Dorigo, D., Laviani, M. (1993). Antidepressive Action of Rubidium. In: Placidi, G.F., Dell’Osso, L., Nisticò, G., Akiskal, H.S. (eds) Recurrent Mood Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76646-6_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76646-6_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76648-0

  • Online ISBN: 978-3-642-76646-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics